Discontinued — last reported Q1 '18
Affirm Holdings, Inc. Allowance for Doubtful Accounts Receivable (Current) increased by 6.7% to $24.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.9%, from $18.20M to $24.00M. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 46.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.10M | $7.10M | $13.90M | $12.00M | $13.90M | $10.20M | $11.80M | $12.30M | $12.90M | $11.00M | $12.10M | $13.70M | $14.90M | $17.20M | $17.80M | $18.20M | $18.80M | $20.20M | $22.50M | $24.00M |
| QoQ Change | — | +73.2% | +95.8% | -13.7% | +15.8% | -26.6% | +15.7% | +4.2% | +4.9% | -14.7% | +10.0% | +13.2% | +8.8% | +15.4% | +3.5% | +2.2% | +3.3% | +7.4% | +11.4% | +6.7% |
| YoY Change | — | — | — | — | +239.0% | +43.7% | -15.1% | +2.5% | -7.2% | +7.8% | +2.5% | +11.4% | +15.5% | +56.4% | +47.1% | +32.8% | +26.2% | +17.4% | +26.4% | +31.9% |